We are live on ! Find out more
AAP

Arax Advisory Partners Portfolio holdings

AUM $3.54B
1-Year Est. Return 19.14%
This Fund
S&P 500
This Quarter Est. Return
+6.62%
1 Year Est. Return
+19.14%
3 Year Est. Return
+47.9%
5 Year Est. Return
+48.74%
10 Year Est. Return
AUM
$1.12B
AUM Growth
+$94.2M
Cap. Flow
+$29.6M
Cap. Flow %
2.64%
Top 10 Hldgs %
29.81%
Holding
2,679
New
140
Increased
832
Reduced
416
Closed
65

Sector Composition

Rank Sector Weight
1 Technology 5.59%
2 Healthcare 3.03%
3 Financials 2.86%
4 Industrials 2.37%
5 Consumer Discretionary 2.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FROG icon
2501
JFrog
FROG
$10.4B
$233 ﹤0.01%
8
TBI
2502
Trueblue
TBI
$305M
$229 ﹤0.01%
29
AMPX icon
2503
Amprius Technologies
AMPX
$1.7B
$227 ﹤0.01%
204
RVLV icon
2504
Revolve Group
RVLV
$1.8B
$224 ﹤0.01%
9
-8
-47% -$168
CCO icon
2505
Clear Channel Outdoor Holdings
CCO
$1.23B
$221 ﹤0.01%
138
TLRY icon
2506
Tilray
TLRY
$603M
$220 ﹤0.01%
13
AFRI icon
2507
Forafric Global
AFRI
$289M
$216 ﹤0.01%
19
AMKR icon
2508
Amkor Technology
AMKR
$13.8B
$215 ﹤0.01%
7
PKOH icon
2509
Park-Ohio Holdings
PKOH
$592M
$215 ﹤0.01%
7
OVLY icon
2510
Oak Valley Bancorp
OVLY
$281M
$213 ﹤0.01%
8
LLYVK icon
2511
Liberty Live Group Series C
LLYVK
$9.53B
$206 ﹤0.01%
4
-31
-89% -$1.24K
TNYA icon
2512
Tenaya Therapeutics
TNYA
$175M
$203 ﹤0.01%
105
ATRO icon
2513
Astronics
ATRO
$3.79B
$195 ﹤0.01%
12
RNAC icon
2514
Cartesian Therapeutics
RNAC
$241M
$194 ﹤0.01%
12
TDOC icon
2515
Teladoc Health
TDOC
$1.25B
$193 ﹤0.01%
21
RXRX icon
2516
Recursion Pharmaceuticals
RXRX
$1.68B
$192 ﹤0.01%
29
-326
-92% -$2.34K
PWOD
2517
DELISTED
Penns Woods Bancorp
PWOD
$191 ﹤0.01%
8
ACH
2518
Accendra Health
ACH
$233M
$189 ﹤0.01%
12
ZNTL icon
2519
Zentalis Pharmaceuticals
ZNTL
$343M
$184 ﹤0.01%
50
IVOL icon
2520
Quadratic Interest Rate Volatility and Inflation Hedge ETF
IVOL
$272M
$183 ﹤0.01%
9
MVST icon
2521
Microvast
MVST
$286M
$183 ﹤0.01%
732
SEER icon
2522
Seer Inc
SEER
$120M
$178 ﹤0.01%
90
FNA
2523
DELISTED
Paragon 28, Inc.
FNA
$174 ﹤0.01%
26
-11
-30% -$83
HTB
2524
HomeTrust Bancshares
HTB
$872M
$171 ﹤0.01%
5
BGS icon
2525
B&G Foods
BGS
$287M
$169 ﹤0.01%
19

Similar funds

Arax Advisory Partners's Q3 2024 Portfolio in Review

As of Q3 2024, Arax Advisory Partners held 2,679 positions worth $1.12B, up 9.2% from $1.03B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Arax Advisory Partners's Q3 2024 filing shows 140 new, 832 increased, 416 reduced and 65 closed positions. Its largest new stake was iShares MSCI KLD 400 Social ETF: 739 shares worth $80.4K. The largest sale was First Trust US Equity Opportunities ETF, an estimated $8.47M.

By sector, the portfolio is most concentrated in Technology at 5.6% of assets, down from 5.6% a quarter earlier, followed by Healthcare and Financials.

  • Arax Advisory Partners's largest Q3 2024 buy was iShares MSCI KLD 400 Social ETF: 739 shares worth $80.4K.
  • Arax Advisory Partners added most to iShares Core US Aggregate Bond ETF in Q3 2024, an estimated $28.1M increase.
  • Arax Advisory Partners's biggest Q3 2024 reduction was First Trust US Equity Opportunities ETF, cutting an estimated $8.47M.
  • Arax Advisory Partners fully exited Vanguard Short-Term Inflation-Protected Securities Index Fund in Q3 2024, selling an estimated $259K.
  • Arax Advisory Partners's ten largest holdings make up 30% of its $1.12B portfolio in Q3 2024.
  • Arax Advisory Partners opened 140 new positions and closed 65 in Q3 2024.
  • Arax Advisory Partners's portfolio value rose 9.2% quarter-over-quarter to $1.12B.

Based on Arax Advisory Partners's 13F filing for Q3 2024, filed 6 Nov 2024.